Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on McKesson (MCK – Research Report), with a ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Geneos Wealth Management Inc. increased its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 5.6% in the 4th ...

Verus Financial Partners Inc. decreased its holdings in shares of McKesson Co. (NYSE:MCK – Free Report) by 12.3% during the ...

Austin Private Wealth LLC trimmed its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 8.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and ...

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail ...

County commissioners distributed over $700,000 to addiction recovery and treatment programs from national opioid misuse ...

Harold’s financial expertise and leadership in scaling up high-growth, healthcare companies are an invaluable addition to ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...